Thomas DeLoughery
Thomas DeLoughery
Professor of Medicine, Pathology,and Pediatrics
Verified email at
Cited by
Cited by
Common mutation in methylenetetrahydrofolate reductase: correlation with homocysteine metabolism and late-onset vascular disease
TG Deloughery, A Evans, A Sadeghi, J McWilliams, WD Henner, ...
Circulation 94 (12), 3074-3078, 1996
Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis
TK Liem, KE Yanit, SE Moseley, GJ Landry, TG DeLoughery, CA Rumwell, ...
Journal of vascular surgery 55 (3), 761-767, 2012
Microcytic anemia
TG DeLoughery
New England Journal of Medicine 371 (14), 1324-1331, 2014
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging
GB Toth, CG Varallyay, A Horvath, MR Bashir, PL Choyke, ...
Kidney international 92 (1), 47-66, 2017
Coagulation defects in trauma patients: etiology, recognition, and therapy
TG DeLoughery
Critical care clinics 20 (1), 13-24, 2004
Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies
JJ Shatzel, SR Olson, DL Tao, OJT McCarty, AV Danilov, TG DeLoughery
Journal of thrombosis and haemostasis 15 (5), 835-847, 2017
Bleeding and thrombosis in acute promyelocytic leukemia
A Choudhry, TG DeLoughery
American journal of hematology 87 (6), 596-603, 2012
The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
J Hum, JJ Shatzel, JH Jou, TG Deloughery
European journal of haematology 98 (4), 393-397, 2017
Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency
R Chou, TG DeLoughery
American journal of hematology 67 (3), 197-199, 2001
Iron deficiency anemia
TG DeLoughery
Medical Clinics 101 (2), 319-332, 2017
A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast cell-specific enhancer.
G Henkel, DL Weiss, R McCoy, T Deloughery, D Tara, MA Brown
The Journal of Immunology 149 (10), 3239-3246, 1992
High dose calcitriol may reduce thrombosis in cancer patients
TM Beer, PM Venner, CW Ryan, DP Petrylak, G Chatta, J Dean Ruether, ...
British journal of haematology 135 (3), 392-394, 2006
Single-dose intravenous iron for iron deficiency: a new paradigm
M Auerbach, T Deloughery
Hematology 2016 (1), 57-66, 2016
IVIg for treatment of severe refractory heparin-induced thrombocytopenia
A Padmanabhan, CG Jones, SM Pechauer, BR Curtis, DW Bougie, ...
Chest 152 (3), 478-485, 2017
Evolutionary conservation of the AU-rich 3'untranslated region of messenger RNA.
MA Asson-Batres, SL Spurgeon, J Diaz, TG DeLoughery, GC Bagby
Proceedings of the National Academy of Sciences 91 (4), 1318-1322, 1994
Hemostasis and thrombosis
TG DeLoughery
CRC Press, 2004
T hrombotic issues in transgender medicine: A review
JJ Shatzel, KJ Connelly, TG DeLoughery
American journal of hematology 92 (2), 204-208, 2017
Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or …
EA Neuwelt, MA Pagel, BP Hasler, TG Deloughery, LL Muldoon
Cancer research 61 (21), 7868-7874, 2001
Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery
HK Song, FA Tibayan, EA Kahl, VA Sera, MS Slater, TG Deloughery, ...
The Journal of thoracic and cardiovascular surgery 147 (3), 1036-1040, 2014
Incidence and risk factors for venous thromboembolic disease in podiatric surgery
AH Felcher, RA Mularski, DM Mosen, TM Kimes, TG DeLoughery, ...
Chest 135 (4), 917-922, 2009
The system can't perform the operation now. Try again later.
Articles 1–20